Identifying drug sensitivity and resistance in acute myeloid leukaemia

Addressing the problem of adherence to treatment

Patient and doctor communication and quality of life guidelines

Use of mesenchymal stromal cells against graft-versus-host disease

Next generation sequencing and the monoclonal structure of multiple myeloma

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Retrospective study of optimal treatment for intermediate-risk testes cancer

Effects of age on treatment and outcomes in women with stage IB-IIB cervical cancer

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

MEK inhibitor, trametinib, improves progression free survival in melanoma

SUCCEED trial: Maintenance treatment in advance soft tissue sarcoma

Drug development in small cell and non-small cell lung cancer